It's that the economics don't support the studies that would generate the "evidence" doctors are trained to require
Users experiencing headaches on GLP-1 medications may find electrolyte supplementation particularly beneficial
Novo Nordisks new oral GLP-1, Wegovy pill, is a once-daily pill offering comparable weight-loss results (an average of 13.6% of your body weight) to injectable Wegovy.^ ^Eligible patients lost an average of 13.6% of their body weight in a 64-week clinical trial evaluating 25 mg oral semaglutide compared to those on 2.4 mg injectable semaglutide who lost an average of 14.9% of their body weight in a 68-week clinical trial
and the beneficial effects on cardiovascular risk, as evident from the cardiovascular outcomes trials (Fig
Because the energy spares the most superficial layer of the skin, most of the risks of side effects seen with aggressive lasers or deep chemical peels can be minimized or completely avoided
In addition, beyond lipid digestion, bile acids act as key signaling molecules that regulate hepatic metabolism, gut microbiota, intestinal integrity, and immune as well as glucose and lipid homeostasis through receptors such as the farnesoid X receptor and Takeda-G-protein-receptor-5 [75]